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Introduction
Autism is a severe neuropsychiatric per-
vasive  developmental  disorder  with  an
early childhood onset.  The condition is
recognised in pre-school-age children but it
is a life-long disorder. Its clinical characteri-
sation  includes  impairments  in  social
interactions, communication or language
abnormalities and restricted repetitive or
stereotyped behaviour (American Psychiat-
ric  Association,  2000).  The  repetitive
behaviour consists of repetition of words
and  phrases  in  a  stereotyped  way  and
movements of the limbs and body. These
stereotypical movements may not be spe-
cific for autism because they also occur in
patients with dementia, in particular, fron-
totemporal dementia (Mendez et al., 2005).
The communication deficit persists in chil-
dren with autism (Wray et al., 2005) and
hence early diagnosis of language develop-
ment in autism is important. Impairment
in social interactions could be due to a defi-
cit in spatial focusing of auditory attention
(Teder-Salejarvi et al., 2005). In adolescence,
cognitive ability and social interaction skills
may  improve  in  some  cases  (McGovern
and Sigman, 2005). The risk of developing
autism has been consistently found to be
associated with infantile microcephaly, dif-
ferent kinds of social impairments (Wing,
1997) and accelerated head growth in early
development  (Bolton  et  al.,  2001;
Dementieva et al., 2005). The clinical char-
acteristics of the disorder closely overlap
with  other  related  conditions  such  as
Asperger syndrome and atypical autism
and  hence  autism  is  classified  under  a
broad domain of pervasive developmental
disorders. Although there is some similar-
ity  between  autism  and  Asperger
syndrome, they differ in their natural his-
tory,  age  of  onset  and  sleep  problems
(Simpson, 2003; Polimeni et al., 2005). There
are considerable variations in clinical pres-
entation  and  severity  of  impairment  in
autism among affected individuals even
within the same family. A variety of early
developmental delays have been currently
used to diagnose the autistic condition.
Previous studies have reported a lower130
incidence rate of approximately 4-10 per
10,000 individuals for autism (Smalley et al.,
1988; Gillberg and Wing, 1999). However,
recently it has been found that the inci-
dence of autism is continuously rising with
time (Rutter 2005). For instance, in a recent
study  using  the  International  Statistical
Classification of Diseases, the cumulative
incidence of childhood autism in Japan is
27.2  per  10,000  (Honda  et  al.,  2005).
Similarly, according to the Danish popula-
tion-based study, the incidence rate and
prevalence of childhood autism in children
younger  than  10  years  is  2  per  10,000
(Lauritsen et al., 2004) and in Western Aus-
tralia the incidence in children 4 years of
age is 5.5 per 10,000 (Williams et al., 2005).
In the United States, a population-based
study reported that the prevalence of au-
tism  spectrum  disorders  is  10-60
individuals per 10,000. (Newschaffer et al.,
2005; Barbaresi et al., 2005; Chakrabarti and
Fombonne,  2001;  Yeargin-Allsopp  et  al.,
2003). These values, when taken into con-
sideration, suggest that autism may not be
as rare a disease as previously thought. The
recent increase in prevalence or the vari-
ability among different studies could be
due to methodological variations, differ-
ences  in  diagnostic  criteria,  types  of
measurements  and  geographical  differ-
ences involving environmental factors.
Neuropathology
    The finding that maternal exposure
to the teratogenic agents thalidomide and
misoprostol can cause autism spectrum dis-
orders (Miller et al., 2004; 2005; Miyazaki et
al.,  2005)  implicated  that  errors  in  early
embryonic brain development may be re-
sponsible for autism (Miller et al., 2004).
These  errors  include  ophthalmological
anomalies (Miller et al., 2005), a variety of
systemic malformations, disruption of early
serotonergic neuronal development, cra-
nial nerve palsies and ear malformations.
This pathophysiolgy could be due to an
early developmental failure of the amy-
gdala-fusiform system, visual perceptual
area of the ventral temporal pathway or
other parts of the brain (Schultz, 2005). In
accordance with this notion, several abnor-
malities such as abnormal cortical serotonin
synthesis (Chandana et al., 2005), decrease
in tracer alpha-methyl- tryptophan (AMT)
in the left cortical region and cerebral folate
deficiency have been reported. These er-
rors may contribute to the developmental
delay in autism through various mecha-
nisms  (Moretti  et  al.,  2005).  In  animal
models, an increase in serotonin activity
also was observed during brain develop-
ment.  Additionally,  the  neuropeptides
oxytocin and vasopressin may be involved
in brain disregulation in autism. These hor-
mones  excite  different  neuronal
populations  in  the  amygdala
(Croonenberghs et al., 2005; Huber et al.,
2005; Scott and Deneris, 2005; Whitaker-
Azmitia, 2005; Lim et al., 2005) and hence
may cause different clinical characteristics
of autism. The neuronal involvement in
autism is further supported by the observa-
tion that the antiepileptic drug valproate
causes a variety of malformations such as
an increase in neural tube defects, develop-
mental  delays,  autism,  limb  defects,
cardiovascular  abnormalities  and
endocrinological  disorders  (Alsdorf  and
Wyszynski  2005).  These  results  strongly
suggest that disregulation of the brain may
be the major cause of autism.
    There is no single region of the brain
that has been identified as being associ-
ated  with  autism.  However,  there  are
several key brain structures that have been
implicated  in  social  cognition  deficit  in
autism. These include the amygdala (FIG-
URE  1),  the  superior  temporal  sulcus131
region and the fusiform gyrus (Pelphrey et
al.,  2004).  Additionally,  behavioural
imaging  and  postmortem  studies  have
shown the signs of structural mal-develop-
ment of frontal lobe, cerebellum, limbic
system  and  related  inferior  olive  -  a
precerebellar structure (FIGURE 1). There
is also evidence for the localised enlarge-
ment  of  the  frontal  cortex  in  autism
(Carper and Courchesne, 2005). In the lim-
bic system, the hippocampus, amygdala
and entorhinal cortex have shown an in-
crease in packing density and small cell
size. In the cerebellum, Purkinje cells are
significantly  reduced  which  again  indi-
cates  the  abnormal  brain  development.
This is consistent with experiments involv-
ing primates in which early hippocampal
damage produced stereotypes and loss of
social  affiliation  (Bauman  and  Kemper
2005). The inferior olive neurons are rela-
tively disrupted in autism. These neurons
generate rhythmical oscillation in mem-
brane potential. When these olive neurons
are impaired they are perhaps unable to
rapidly process sequences of cues for the
development  of  normal  language  skills
(Welsh et al., 2005). Based on these as well
as other observations it was hypothesised
that an imbalance between excitation and
inhibition in key neuronal systems might
cause autism (Cline, 2005).
The relationship between repetitive be-
haviour and associated clinical features in
autism  is  complex.  However,  repetitive
behaviour or circling is one of the defining
features of autism. In animal models, the
induction of circling may be determined
by  the  GABAergic  substantia  nigra
reticulata  and  dopaminergic  substantia
nigra  compacta  (Gabriels  et  al.,  2005;
Velisek et al., 2005). Similarly, there may be
a  localised  dysfunction  of  the  temporal
lobe (Bachevalier, 1994), hippocampal for-
mation, reduced white matter volume in
corpus  callosum  (FIGURE  1)  and  right
hemisphere and other widely distributed
abnormalities  of  neuronal  organisation
and connectivity in the brain (Minshew et
al., 2004; Polleux and Lauder, 2004). Be-
cause the various regions of the brain are
shown to be involved in autism, it is pos-
FIGURE 1
A schematic illustration of the locations of the brain regions that are implicated in autism
disorder. The figure shows the location of amygdala, hippocampus, cerebellum and corpus
callosum
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sible that a specific neurological dysfunc-
tion can produce a characteristic symptom.
For instance, the substantia nigra may be
involved in one such symptom as circling
behaviour and oxytocin and vasopressin
in amygdala and abnormal synthesis of
serotonin in the cortical region may deter-
mine  other  characteristic  features  of
autism (Zwaigenbaum et al., 2005). In spite
of this, a specific cognitive deficit in autism
has not been found (Carvajal-Molina et al.,
2005)  and  there  are  no  universally  ac-
cepted  changes  in  brain  structure,  cell
composition and clinical or biomarkers for
autism (Beauregard et al., 1995; Bauman,
1996; Zilbovicius et al., 2000; Waiter et al.,
2005).
Chromosomal abnormalities
Autism is a complex multi-factorial de-
velopmental disorder with a strong genetic
component. Cytogenetic studies reveal that
approximately 1.7 to 4.8% of individuals
with autism have chromosomal abnormali-
ties (Reddy, 2005). A variety of structural
abnormalities (TABLE I) including duplica-
tion, inversion, deletion and translocation
have been reported (reviewed in Shastry,
2003). The most common abnormality is
the duplication of the proximal region of
the long arm of chromosome 15 (i.e. 15q).
For instance, a partial duplication of chro-
mosome 15 that involves the Prader-Willi/
Angelman syndrome critical region (15q11-
q13)  has  been  found  in  three  cases  of
autism. Similarly, a paternally derived in-
terstitial duplication in the same critical
region (15q11-q13) was also found in a fe-
male patient (Veltman et al., 2005).  This
suggests that in some cases, genomic im-
printing may be involved in autism (Simie
and Turk, 2004; Samaco et al., 2005). When
pathology is considered, patients with in-
terstitial  deletions  in  chromosome  12
exhibit  mental  retardation  and  develop-
mental delay while patients with deletion
in chromosome 18 show communication
problems and mental retardation. Similarly,
inversion in chromosome 17 is associated
with  developmental  delay.  Although  in
some cases deletion ranged from 5 to 260
Kb and patients exhibited a varying degree
of  intellectual  impairments,  there  is  no
clustering of break points involved and de-
letions  are  scattered  throughout  the
genome.  Interestingly,  in  a  population-
based study, a minority of cases of autism
have been found to be associated with mi-
tochondrial  dysfunction  (Oliveira  et  al.,
TABLE I
A partial list of cytogenetic abnormalities associated with autism
Deletion at marker D7S630 Deletion at marker D7S517
Deletion at marker D8S264 Partial duplication of 7p
Interstitial duplication of proximal 15q Deletion in 2q, 3q, 18q and Xp
del (12)(p11.2 q21.2) del (13)(q13.2 q14.1)
inv (10)(p11.2 q21.2) inv (17)(q2 q25)
t(7; 13)(q31.3; q21) t(5; 7)(q14; q32)
t(1; 14)(q25; q31.2)
del = deletion; inv = inversion; t = translocation133
2005). Therefore, it could be a mitochon-
drial disorder as well. However, it requires
further  investigation.  The  above  studies
taken  together  suggest  that  autism  is  a
polygenic disorder.
Linkage analysis
    The genetic aetiology of autism re-
mains  elusive  both  at  the  cellular  and
molecular levels. While the existing genetic
data  do  not  strongly  support  any  one
mode of inheritance, twin and family stud-
ies  endorse  a  multi-locus  aetiology.  For
instance,  multiple  studies  reported  that
identical (monozygotic) twins are 60-90%
concordant for autism (Folstein and Rutter
1977; Ritvo et al., 1985; Steffenburg et al.,
1989; Bailey et al., 1995; Folstein and Rutter,
1997).  On  the  other  hand,  nonidentical
(dizygotic) twins and siblings have a much
lower (0 – 20%) concordance rate (August
and  Stewart,  1981;  Bolton  et  al.,  1994;
Lauritsen  and  Ewald,  2001).  When  a
broader  phenotype  of  autism  was  in-
cluded, the concordance rate was increased
to 92% and 10% for monozygotic and dizy-
gotic  twins  respectively  (Folstein  and
Rutter, 1977). Additionally, prevalence of
autism is found to be 3 to 4 fold higher in
males than in females (Folstein and Rosen-
Sheidley, 2001) and the reason for this is
unknown. However, this may suggest that
sex-specific factors might be involved in its
development. In accordance with this no-
tion, evidence for sex-limited and parent of
origin specific effects in the aetiology of
autism have been reported (Lamb et al.,
2005). Interestingly, a male specific region
of linkage on chromosome 17q was also
recently reported in the autism spectrum
disorder (Stone et al., 2004). It is not sur-
prising that such a sex-specific effect may
exist because it is already known that male
and female brains develop and function
differently. In addition, there may be mi-
croscopic  structural  differences  between
male and female brains (Wisniewski, 1998;
Wrase et al., 2003).
     These monozygotic and dizygotic
concordance rates indicate that both ge-
netic and environmental factors contribute
to the risk of developing autism. Although
previously it was reported that measles,
mumps  and  rubella  (MMR)  vaccination
might cause autism, recently it was found
that there is no such association (Taylor et
al., 1999) indicating that MMR vaccine is
not an environmental risk factor for au-
tism. The higher concordant rate (90%) in
monozygotic twins and the marked differ-
ence  between  the  mono-  and  dizygotic
concordance rate suggest that autism is
highly heritable and the genetic basis is
complex. It is likely that multiple genes
contribute to autism susceptibility in an
interactive manner, but the exact number
of contributing genes and their modes of
inheritance are not known. However, ten
genome wide linkage studies have shown
suggestive evidence for linkage on 17 of
the 22 autosomes and at various locations
on the X-chromosome (Barrett et al., 1999;
Philippe  et  al.,  1999;  Risch  et  al.,  1999;
Buxbaum  et  al.,  2001;  Liu  et  al.,  2001;
McCauley  et  al.,  2005;  Santangelo  and
Tsatsanis, 2005). These chromosomal re-
gions  may  contain  one  or  more
susceptibility genes and these may deter-
mine  one  or  all  of  the  clinical
characteristics  of  autism.  However,  it
should  be  noted  that  several  of  these
analyses reported only moderate positive
signals on several chromosomes and only
a  few  regions  appear  to  be  consistent
across  studies  (Folstein  and  Rosen-
Sheidley,  2001;  Yonan  et  al.,  2003).  The
most consistent finding, to date, has been
on chromosome 2q, 7q, 15q and 17q11-q22
(Cantor  et  al.,  2005;  Santangelo  and134
Tsatsanis 2005) with a possibility of chro-
mosome  1  (Badner  and  Gershon,  2002;
Bartlett et al., 2005a). It is still not clear
whether these are the major susceptibility
loci for autism or other loci also influence
the disorder. One of the reasons for incon-
sistency in linkage could be due to locus
heterogeneity or sample size or both.
These linkage studies and the drop in
the concordance rate between monozy-
gotic and dizygotic twins suggest that a
single gene is not responsible for disease
expression  and  the  genetic  aetiology  of
autism is heterogeneous (different family
has different genes). It is a polygenic dis-
order (an individual may carry more than
one defective gene) with epigenetic influ-
ences (Folstein and Rosen-Sheidley, 2001)
and with allelic heterogeneity (different
variants in the same gene). Different ge-
netic  factors  may  be  associated  with
different characteristic features of autism
such as poor social interactions, communi-
cation and repetitive behaviour. Evidence
that  thalidomide  induces  embryopathy
and  less  than  100%  concordance  rate
among monozygotic twins also suggests
the involvement of environmental factors.
In addition, social and emotional factors
may also play a role in autism (Simpson,
2003;  Santangelo  and  Tsatsanis,  2005).
Thus, it appears that autism is a syndrome
with a strong genetic component.
Candidate gene analysis
    When linkage analysis was extended
to identify autism susceptibility candidate
genes, most of the results are either con-
flicting with the other studies or resulted
in  frustration.  Many  genes  which  are
known for their role in brain functions did
not show association with the condition
(TABLE  II).  However,  serotonin  trans-
porter intron-2 polymorphism (Mulder et
al., 2005), Reelin (reeler mutant mouse has
cerebral cortex malformation), tryptophan
hydroxylase (Bartlett et al., 2005b; Coon et
al., 2005), neuroligins 3 and neuroligins 4
(Jamain et al., 2003) and genes mapping to
chromosome 7q (Bonora et al., 2005) have
been found to have some role in autism.
The region on 7q35 may contain a gene
that may be related to the variability in
spoken language (Alarcon et al., 2005), but
these findings have to be replicated by
other studies. In a sub-population of autis-
tic  patients,  increased  blood  levels  of
5-hydroxy tryptamine (5-HT) have been
repeatedly observed. Therefore, it is possi-
ble that disrupted developmental control
of  5-HT  production  in  autistic  children
could  result  in  hyperserotonaemia  and
this may have a role in specific aspects of
the  behaviour  (Chugani  et  al.,  1999;
Leboyer et al., 1999). Similarly, neuroligins
are needed for the formation of morpho-
logically well- differentiated synapses and
they  mediate  excitatory  and  inhibitory
synapse  formation.  They  carry  out  this
function by binding to neurexin. Muta-
tions  in  these  genes  may  affect  cell
adhesion molecules located at the synapse
and  impair  its  cell  surface  transport
(Chubykin  et  al.,  2005;  Levinson  et  al.,
2005). In the same way, Reelin may also act
as a terminal signal for neurons at the end
of their migration pathway and the re-
duced  amount  of  reelin  mRNA  in  the
frontal and cerebellar area may suggest an
impairment in the reelin signalling system
in autism (Fatemi et al., 2005). Although
these studies have given a wealth of infor-
mation, research to date on the genetics of
autism has not uncovered a major suscep-
tibility locus (there may not be any such
locus) despite considerable efforts. In addi-
tion,  only  a  few  candidate  genes  have
been shown to display specific mutations
that segregate with autism but these are135
yet to be replicated. Those genes which
are responsible for controlling the early
patterning  of  specific  neuronal  sub-
populations and their regulation during
development are also likely to be involved
in autism.
Summary
    Autism is a complex behaviourally
defined childhood developmental disor-
der  without  an  established  aetiology.
Currently a variety of early developmental
delay and regressions in behaviour have
been used to diagnose the condition. The
social and behavioural deficits are the hall-
marks  of  autism.  Autistic  spectrum
disorders  have  profound  effects  on  the
lives of patients and their families. It is a
syndrome with a strong genetic compo-
nent and has a heritability value of about
90%. However, the transmission pattern
does not follow any one mode of inherit-
ance. Although many regions of the brain
are shown to be involved in autism there
are no universally accepted changes in the
brain structure. Despite considerable ef-
forts to identify chromosomal regions and
genes, no disease genes have been identi-
fied which can account for major portions
of autism disorder. The positive association
studies of some candidate genes still need
to be replicated by others. There are no
physical  tests  that  can  be  of  diagnostic
value  or  drugs  that  can  produce  major
benefits for autistic disorders. Behavioural
therapy, environmental management and
structured education may be the most ef-
fective way to help the affected children.
Additionally,  antipsychotic  medication
may have some limited effects to reduce
the level of physical aggression. In the fu-
ture,  investigation  of  genetic  and
environmental factors may help provide
better diagnosis and treatment.
TABLE II
A partial list of genes that are unlikely associated with autisma
Hox A1 and Hox B1 Dopamine receptors D2 and D5
Reelin Monoamine oxidase A and B
DLX6 Brain derived neurotrophic factor
FOXP2 Neural cell adhesion molecule
DOPA decarboxylase Genes in 800 Kb region of 7q32
Proenkephalin Methyl-CpG-binding protein 2
Tyrosine hydroxylase Catechole-O-methyltransferase
Dopamine D4 exon III (DRD4) Prodynorphine
WNT-2 Piccolo gene
CPA1 and CPA5
a = detailed references can be found in Shastry, 2003; DLX5 and Piccolo = genes in
chromosome 7q21-q22; FOXP2 = one of the genes in chromosome 7q31; CAP1 and CAP5
= members of the carboxypeptidase gene family located at chromosome 7q32; Hox A1 and
Hox B1 = homeobox genes; WNT-2 = secreted cystein-rich glycoprotein136
Glossary
Amygdala
Portion of the limbic system that func-
tions to add emotional overtones to
memories.
Association
Groups of anomalies that occur together
more often than chance.
Autosomes
Any chromosome other than the X or Y
chromosomes
Candidate gene
A gene mapped to a region known to be
linked to a specific disease.
Cerebellum
Part of the brain located posterior to the
medulla oblongata.
Chromosome
Genetic material complexed with RNA
and proteins to form a thread like
structure.
Corpus Callosum
A mass of white matter within the brain.
Cytogenetics
The study of chromosome structure.
Deletion
The loss of chromosomal material.
Dizygotic
The product of fertilization of two
separate eggs by two separate sperms,
resulting in non-identical twin pairs.
Dopamine
Transmitter liberated by neurons in some
autonomic ganglia and in the central
nervous system.
Duplication
A chromosomal aberration in which the
segment of the chromosome is repeated.
GABA
Gamma aminobutyric acid, an inhibitory
neurotransmitter.
Gene
The fundamental physical unit of hered-
ity.
Genome
The complete set of genes in an organ-
ism.
Genotype
Genetic make-up of an individual
Hippocampus
A region of the brain involved in learn-
ing, generation of emotions and memory.
Idiopathic
A disease or condition for which causes
are unknown.
Insertions
The addition of DNA sequence.
Interstitial deletion
Deletion that removes part of the interior
of the chromosome.
Inversion
A chromosomal aberration in which the
order of a chromosomal segment has
been reversed.
Karyotype
The chromosomal complement of a cell
or an individual.
Killobase pairs
A unit of measurement used in genetics
to denote 1000 bases of DNA137
Linkage
Describes two loci that are located close
enough on the same chromosome.
Mitochondria
The cells power house generating energy.
Monogenic
Controlled by only one gene.
Monozygotic
Arising from a single fertilized egg,
resulting in genetically identical twins.
Mutation
The process that produces an alteration
in DNA or chromosome structure.
Oxytocin
Hormone secreted from posterior pitui-
tary.
Polygenic
Controlled by more than one gene.
Polymorphism
The existence of two or more genetically
determined forms in a population.
Reelin (relin)
A large extra-cellular matrix protein gene
involved in neuronal migration.
Rubella
German measles.
Serotonin
5-hydroxytryptamine (5HT), a neuro-
transmitter.
Sex chromosome
X or Y-chromosomes determining gender.
Teratogenic
Capable of producing abnormal develop-
ment of a foetus.
Transmitter
Chemical substance liberated by a presy-
naptic nerve terminal.
Translocation
A chromosomal mutation associated with
the transfer of a chromosomal segment
from one chromosome to another.
Vasopressin
Peptide hormone secreted by
hypothalamus
White matter
Part of the central nervous system
appearing white.
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